2796 — Pharmarise Holdings Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMicro CapValue Trap

Annual balance sheet for Pharmarise Holdings, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

	2020 May 31st	2021 May 31st	2022 May 31st	2023 May 31st	2024 May 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4,472	4,604	3,991	4,742	7,150
Net Total Accounts Receivable
Net Total Receivables	3,323	3,085	4,265	4,017	3,553
Total Inventory
Total Other Current Assets
Total Current Assets	10,676	10,546	10,878	11,372	13,737
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,332	6,434	6,355	6,010	6,198
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	25,206	24,724	23,746	23,421	29,486
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,036	9,392	8,477	9,835	10,688
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	19,297	18,503	17,138	16,539	22,124
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,909	6,221	6,608	6,882	7,362
Total Liabilities & Shareholders' Equity	25,206	24,724	23,746	23,421	29,486
Total Common Shares Outstanding